# Navinta, LLC – FDA Inspection, May 16, 2016

Source: https://www.keypedia.com/records/fda_inspections/navinta-llc/00d89d55-9f1e-4732-b227-af5f6a4f6e36
Source feed: FDA_Inspections

> FDA inspection 971010 of Navinta, LLC, May 16, 2016. Classification: Official Action Indicated (OAI). 3 citations under 21 CFR part 314. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 971010
- Company Name: Navinta, LLC
- Inspection Date: 2016-05-16
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1252822 - 2024-09-30
- [FDA Inspection 1209856 - 2023-06-29](https://www.keypedia.com/records/fda_inspections/navinta-llc/a32b14ce-5c4a-4a08-acb7-8ebf80958519)
- FDA Inspection 1205480 - 2023-05-04
- [FDA Inspection 1084188 - 2019-03-28](https://www.keypedia.com/records/fda_inspections/navinta-llc/e5f0a259-43ef-4701-adfe-5b2f94d30760)
- [FDA Inspection 1070302 - 2018-09-18](https://www.keypedia.com/records/fda_inspections/navinta-llc/89d9cbd4-879b-471f-8a04-efacf0821bff)

Company: https://www.keypedia.com/companies/navinta-llc/2049d986-174a-414f-812b-0f4347426e48

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c